Curisium’s platform employs blockchain and secure computation technologies to enable users to securely engage in value-based contracts. The company aims to enable value-based care contracting at the individual patient level.
“Curisium’s platform, by enabling outcome verification at the patient level, while automating the payment side, has the potential to rapidly accelerate the breadth and depth of innovative contracting arrangements,” said Bill Geary, co-founder and Partner at Flare Capital, a seed round investor.
Additionally, Curisium added Bill Geary of Flare Capital and Mohamad Makhzoumi of New Enterprise Associates to its board of directors.
More articles on health IT:
Apple names mindfulness app Calm its iPhone app of 2017
Former IBM Watson oncologist named VP of precision medicine startup: 4 things to know
Allscripts CEO Paul Black talks McKesson acquisition, 2018 goals: 6 questions
